Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hepatitis B Core Antigens | 1 | 2019 | 76 | 0.76 | Why? |
| Hepatitis E virus | 3 | 2017 | 306 | 0.75 | Why? |
| Hepatitis B e Antigens | 1 | 2019 | 99 | 0.75 | Why? |
| Hepatitis E | 3 | 2017 | 319 | 0.71 | Why? |
| Nucleotides | 1 | 2019 | 212 | 0.65 | Why? |
| Embryo, Mammalian | 1 | 2016 | 86 | 0.63 | Why? |
| Amniotic Fluid | 1 | 2016 | 249 | 0.57 | Why? |
| Hepatitis B, Chronic | 1 | 2019 | 616 | 0.47 | Why? |
| Abortion, Spontaneous | 1 | 2016 | 776 | 0.42 | Why? |
| Zika Virus Infection | 3 | 2017 | 1920 | 0.37 | Why? |
| Zika Virus | 2 | 2017 | 1924 | 0.32 | Why? |
| Virus Shedding | 2 | 2021 | 5834 | 0.28 | Why? |
| Netherlands | 10 | 2021 | 3533 | 0.23 | Why? |
| Liver Diseases | 1 | 2017 | 2698 | 0.22 | Why? |
| Liver Transplantation | 1 | 2017 | 2864 | 0.22 | Why? |
| Placenta Diseases | 1 | 2021 | 180 | 0.19 | Why? |
| Steam | 1 | 2020 | 132 | 0.19 | Why? |
| Placenta | 2 | 2021 | 1531 | 0.18 | Why? |
| Hepatitis C Antigens | 1 | 2017 | 18 | 0.18 | Why? |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2017 | 40 | 0.17 | Why? |
| Sterilization | 1 | 2020 | 294 | 0.16 | Why? |
| Yellow fever virus | 1 | 2019 | 205 | 0.16 | Why? |
| Mink | 1 | 2020 | 399 | 0.16 | Why? |
| Insect Vectors | 1 | 2019 | 227 | 0.16 | Why? |
| Disposable Equipment | 1 | 2020 | 332 | 0.16 | Why? |
| Yellow Fever | 1 | 2019 | 231 | 0.15 | Why? |
| Brachial Plexus Neuritis | 1 | 2017 | 130 | 0.15 | Why? |
| Genotype | 2 | 2019 | 4697 | 0.15 | Why? |
| Preventive Health Services | 1 | 2020 | 501 | 0.14 | Why? |
| Travel | 4 | 2021 | 7220 | 0.14 | Why? |
| Pregnancy Complications, Infectious | 2 | 2021 | 11559 | 0.14 | Why? |
| Caliciviridae Infections | 1 | 2017 | 229 | 0.14 | Why? |
| Pregnancy Trimester, First | 1 | 2016 | 366 | 0.14 | Why? |
| Zoonoses | 2 | 2020 | 3034 | 0.13 | Why? |
| Norovirus | 1 | 2017 | 294 | 0.13 | Why? |
| Fetal Death | 1 | 2016 | 390 | 0.13 | Why? |
| Ships | 1 | 2021 | 1046 | 0.12 | Why? |
| Liver Function Tests | 1 | 2019 | 1325 | 0.12 | Why? |
| Whole Genome Sequencing | 5 | 2020 | 3239 | 0.11 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.11 | Why? |
| Hepatitis B virus | 1 | 2019 | 882 | 0.11 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.11 | Why? |
| Serologic Tests | 3 | 2020 | 4359 | 0.11 | Why? |
| Immunocompromised Host | 2 | 2017 | 5150 | 0.11 | Why? |
| Dengue Virus | 1 | 2017 | 910 | 0.10 | Why? |
| Multivariate Analysis | 1 | 2021 | 5440 | 0.10 | Why? |
| Travel-Related Illness | 1 | 2017 | 1357 | 0.10 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.09 | Why? |
| Viremia | 1 | 2016 | 1020 | 0.09 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.09 | Why? |
| Seroconversion | 1 | 2019 | 2515 | 0.09 | Why? |
| DNA, Viral | 1 | 2019 | 2521 | 0.09 | Why? |
| Seizures | 1 | 2017 | 1163 | 0.09 | Why? |
| Respiratory System | 1 | 2021 | 3213 | 0.09 | Why? |
| Community-Acquired Infections | 1 | 2020 | 2328 | 0.09 | Why? |
| Genome, Viral | 2 | 2020 | 13157 | 0.08 | Why? |
| RNA, Viral | 6 | 2021 | 32276 | 0.08 | Why? |
| Camelus | 1 | 2015 | 1425 | 0.08 | Why? |
| Antiviral Agents | 2 | 2019 | 41703 | 0.08 | Why? |
| Hepatitis C | 1 | 2017 | 1514 | 0.07 | Why? |
| Chronic Disease | 2 | 2017 | 5139 | 0.07 | Why? |
| Molecular Diagnostic Techniques | 1 | 2021 | 4239 | 0.07 | Why? |
| Dengue | 1 | 2017 | 1565 | 0.07 | Why? |
| Evolution, Molecular | 1 | 2017 | 3691 | 0.07 | Why? |
| Respiratory Tract Infections | 2 | 2015 | 6817 | 0.07 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 2 | 2015 | 8843 | 0.06 | Why? |
| Humans | 23 | 2021 | 930598 | 0.06 | Why? |
| Brain Ischemia | 1 | 2017 | 2813 | 0.06 | Why? |
| Fetal Distress | 1 | 2021 | 70 | 0.06 | Why? |
| Adult | 11 | 2021 | 244371 | 0.05 | Why? |
| Female | 11 | 2021 | 380317 | 0.05 | Why? |
| Cross Infection | 2 | 2020 | 8675 | 0.05 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.05 | Why? |
| Naval Medicine | 1 | 2021 | 104 | 0.05 | Why? |
| Trophoblasts | 1 | 2021 | 237 | 0.05 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.05 | Why? |
| Gambia | 1 | 2019 | 145 | 0.05 | Why? |
| Farms | 1 | 2020 | 269 | 0.05 | Why? |
| Insect Bites and Stings | 1 | 2019 | 63 | 0.05 | Why? |
| Male | 11 | 2021 | 367725 | 0.05 | Why? |
| Senegal | 1 | 2019 | 283 | 0.04 | Why? |
| Pregnancy | 2 | 2021 | 23879 | 0.04 | Why? |
| Suriname | 1 | 2017 | 21 | 0.04 | Why? |
| Likelihood Functions | 1 | 2020 | 719 | 0.04 | Why? |
| Disease Outbreaks | 3 | 2021 | 27595 | 0.04 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.04 | Why? |
| Masks | 1 | 2020 | 8528 | 0.04 | Why? |
| Antibodies, Viral | 3 | 2020 | 51949 | 0.04 | Why? |
| Hepatitis Antibodies | 1 | 2017 | 100 | 0.04 | Why? |
| Occupational Exposure | 1 | 2015 | 4742 | 0.04 | Why? |
| Phylogeny | 3 | 2020 | 13341 | 0.04 | Why? |
| Biomarkers | 1 | 2019 | 23361 | 0.04 | Why? |
| Contact Tracing | 1 | 2015 | 8448 | 0.04 | Why? |
| Liver Failure, Acute | 1 | 2019 | 279 | 0.04 | Why? |
| Mutation Rate | 1 | 2017 | 382 | 0.04 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| Luminescent Measurements | 1 | 2020 | 924 | 0.04 | Why? |
| Statistics as Topic | 1 | 2017 | 370 | 0.03 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.03 | Why? |
| Neurologic Examination | 1 | 2017 | 428 | 0.03 | Why? |
| Saudi Arabia | 2 | 2015 | 4423 | 0.03 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.03 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 7868 | 0.03 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.03 | Why? |
| Qatar | 1 | 2015 | 784 | 0.03 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2017 | 11367 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2020 | 1609 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.03 | Why? |
| High-Throughput Screening Assays | 1 | 2020 | 1783 | 0.03 | Why? |
| Ribavirin | 1 | 2017 | 1182 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Young Adult | 5 | 2020 | 93724 | 0.02 | Why? |
| Middle East | 1 | 2014 | 1418 | 0.02 | Why? |
| Syndrome | 1 | 2014 | 1310 | 0.02 | Why? |
| Disease Reservoirs | 1 | 2017 | 1672 | 0.02 | Why? |
| Pregnancy Outcome | 1 | 2021 | 3803 | 0.02 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2020 | 3755 | 0.02 | Why? |
| Genetic Variation | 1 | 2020 | 3919 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.02 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.02 | Why? |
| Cross Reactions | 1 | 2017 | 4374 | 0.02 | Why? |
| Immunoglobulins, Intravenous | 1 | 2017 | 2705 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Coronavirus | 1 | 2014 | 18339 | 0.02 | Why? |
| Animals | 3 | 2020 | 78931 | 0.02 | Why? |
| Feces | 1 | 2017 | 4235 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2019 | 6740 | 0.02 | Why? |
| Risk | 1 | 2015 | 5288 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.01 | Why? |
| Survival Analysis | 1 | 2015 | 7592 | 0.01 | Why? |
| Adolescent | 3 | 2017 | 86841 | 0.01 | Why? |
| France | 1 | 2017 | 12074 | 0.01 | Why? |
| Mutation | 1 | 2020 | 12376 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Treatment Outcome | 2 | 2017 | 51732 | 0.01 | Why? |
| Immunoglobulin M | 1 | 2017 | 9091 | 0.01 | Why? |
| Viral Nonstructural Proteins | 1 | 2017 | 4810 | 0.01 | Why? |
| Acute Kidney Injury | 1 | 2019 | 5762 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2015 | 8248 | 0.01 | Why? |
| Child | 2 | 2017 | 70012 | 0.01 | Why? |
| United Kingdom | 1 | 2017 | 18046 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 13720 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2017 | 21571 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2015 | 43792 | 0.01 | Why? |
van der Eijk's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(155)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(123)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_